Johnson & Johnson has paused its clinical trials for a Covid-19 vaccine candidate after a participant fell ill, just weeks after it announced that trials were in their final stage.
A pause is not entirely unexpected in vaccine trials. When another vaccine trial was temporarily stopped last month, experts hailed the move as an example of the scientific rigor that is being maintained despite the understandably intense public interest in a Covid-19 vaccine.
